Details for New Drug Application (NDA): 020610
✉ Email this page to a colleague
The generic ingredient in COLAZAL is balsalazide disodium. There are ten drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the balsalazide disodium profile page.
Summary for 020610
Tradename: | COLAZAL |
Applicant: | Valeant Pharms Intl |
Ingredient: | balsalazide disodium |
Patents: | 2 |
Suppliers and Packaging for NDA: 020610
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
COLAZAL | balsalazide disodium | CAPSULE;ORAL | 020610 | NDA | Salix Pharmaceuticals, Inc | 65649-101 | 65649-101-02 | 280 CAPSULE in 1 BOTTLE (65649-101-02) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 750MG | ||||
Approval Date: | Jul 18, 2000 | TE: | AB | RLD: | Yes | ||||
Patent: | ⤷ Sign Up | Patent Expiration: | Feb 24, 2027 | Product Flag? | Substance Flag? | Delist Request? | Y | ||
Patent: | ⤷ Sign Up | Patent Expiration: | Feb 24, 2027 | Product Flag? | Substance Flag? | Delist Request? | Y |
Expired US Patents for NDA 020610
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Valeant Pharms Intl | COLAZAL | balsalazide disodium | CAPSULE;ORAL | 020610-001 | Jul 18, 2000 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription